Pacer Advisors Inc. Raises Stock Position in USANA Health Sciences, Inc. (NYSE:USNA)

Pacer Advisors Inc. raised its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 16.5% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 544,256 shares of the company's stock after buying an additional 76,904 shares during the period. Pacer Advisors Inc. owned about 2.86% of USANA Health Sciences worth $20,638,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of USNA. Pzena Investment Management LLC lifted its stake in shares of USANA Health Sciences by 7.5% in the 3rd quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company's stock valued at $39,801,000 after purchasing an additional 72,977 shares during the period. Dimensional Fund Advisors LP increased its holdings in USANA Health Sciences by 0.6% in the second quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company's stock valued at $30,907,000 after buying an additional 3,889 shares in the last quarter. American Century Companies Inc. raised its position in shares of USANA Health Sciences by 12.3% in the second quarter. American Century Companies Inc. now owns 159,782 shares of the company's stock worth $7,229,000 after acquiring an additional 17,460 shares during the period. Assenagon Asset Management S.A. boosted its stake in shares of USANA Health Sciences by 13.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company's stock worth $4,702,000 after acquiring an additional 14,756 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. grew its position in shares of USANA Health Sciences by 2.6% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 111,492 shares of the company's stock valued at $5,407,000 after acquiring an additional 2,820 shares during the period. Institutional investors and hedge funds own 54.25% of the company's stock.

USANA Health Sciences Stock Performance

Shares of USNA traded up $0.54 during trading hours on Friday, hitting $39.90. 83,195 shares of the stock were exchanged, compared to its average volume of 84,198. The stock's 50-day moving average price is $37.83 and its two-hundred day moving average price is $41.73. The company has a market cap of $760.49 million, a price-to-earnings ratio of 14.10, a price-to-earnings-growth ratio of 1.34 and a beta of 0.89. USANA Health Sciences, Inc. has a 12-month low of $34.15 and a 12-month high of $54.81.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.07. The business had revenue of $200.22 million for the quarter, compared to analysts' expectations of $208.45 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same period in the previous year, the firm posted $0.59 EPS. On average, research analysts expect that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, DA Davidson dropped their price objective on USANA Health Sciences from $38.00 to $35.00 and set a "neutral" rating on the stock in a report on Wednesday, October 23rd.

Insider Activity

In other news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.33% of the company's stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.